The company
CG Oncology, Inc.
CGON · Nasdaq
CGON stood above a rising 150-day average in 49 of the last 52 weekly readings, and has been out of that trend for the last 3 weeks. It is 9.8% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−14 points in four weeks); Health Care: 28% (−9 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 3
- Industry in uptrend
- 18% -14 in 4 wk
- Insider buys, 12 months
- $49.6M
- Insider sales, 12 months
- $9.6M
- Officials’ trades on record
- 0
- Institutions holding
- 215 (-3)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 49 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Leonard E. PostDirector | sold | 500at $61.65 | 15 Oct 2026filed 19 Oct 2026 |
| Leonard E. PostDirector | sold | 500at $62.48 | 15 Oct 2026filed 19 Oct 2026 |
| Leonard E. PostDirector | sold | 1,000at $72.98 | 15 Sep 2026filed 17 Sep 2026 |
| Leonard E. PostDirector | sold | 1,000at $74.54 | 14 Aug 2026filed 18 Aug 2026 |
| Leonard E. PostDirector | sold | 1,000at $71.17 | 15 Jul 2026filed 17 Jul 2026 |
| James MulayDirector | sold | 24,165at $75.16 | 10 Jul 2026filed 14 Jul 2026 |
| Brian Guan-Chyun LiuDirector | bought | 371,085at $66.87 | 25 Jun 2026filed 29 Jun 2026 |
| Leonard E. PostDirector | sold | 5,000at $70.00 | 24 Jun 2026filed 25 Jun 2026 |
| Leonard E. PostDirector | sold | 5,000at $65.00 | 22 Jun 2026filed 23 Jun 2026 |
| James MulayDirector | sold | 654at $60.12 | 15 Jun 2026filed 16 Jun 2026 |
| James MulayDirector | sold | 1,310at $60.12 | 15 Jun 2026filed 16 Jun 2026 |
| Leonard E. PostDirector | sold | 1,000at $54.50 | 4 Jun 2026filed 5 Jun 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| RTW INVESTMENTS, LPadded · filed 14 Aug 2026 | 8,514,590$605.0M | +1,529,782+21.9% |
| Decheng Capital LLCunchanged · filed 14 Aug 2026 | 6,371,669$452.7M | 00.0% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 6,256,288$444.5M | +1,192,108+23.5% |
| WELLINGTON MANAGEMENT GROUP LLPreduced · filed 14 Aug 2026 | 5,324,751$378.3M | -46,481−0.9% |
| FMR LLCadded · filed 13 Aug 2026 | 4,161,493$295.7M | +396,649+10.5% |
| TCG Crossover Management, LLCunchanged · filed 14 Aug 2026 | 3,670,206$260.8M | 00.0% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 3,465,197$246.2M | +370,099+12.0% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 3,437,590$244.2M | +790,536+29.9% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 3,316,793$235.7M | +283,168+9.3% |
| Foresite Capital Management VI LLCadded · filed 14 Aug 2026 | 2,369,574$168.4M | +148,100+6.7% |
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.